Stocks
Clover Health Investments (CLOV) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -39.5% | -13.7% | -43.2% | -10.6% | -8.88% | -9.37% | ||
| Changes by years, y/y, % | +26pp | -29pp | +33pp | +2pp | -31.1% | ||||
Clover Health Investments. EBITDA margin, %
Clover Health Investments. EBITDA margin, changes, pp
Clover Health Investments (CLOV) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -4.49% | -8.21% | -12.7% | -9.29% | -6.12% | -9.37% | |
| Changes by years, y/y, % | +8pp | +0pp | -1pp | +3pp | +8pp | |||
| Changes by quarters, q/q, % | +9pp | -4pp | -5pp | +3pp | +3pp | |||
